Burkholderia pseudomallei
**Clinical Context & Diagnostic Yield:** In the workup of Embolic Stroke of Undetermined Source (ESUS), the choice between Transthoracic Echocardiography (TTE) and Transesophageal Echocardiography (TEE) is critical. While TTE is non-invasive and excellent for assessing ventricular function and large thrombi, it has sigβ¦
**Treatment Equivalence (IVIG vs. PEX):** According to the EFNS/PNS (European Federation of Neurological Societies/Peripheral Nerve Society) and AAN (American Academy of Neurology) guidelines, both Intravenous Immunoglobulin (IVIG) and Plasma Exchange (PEX) are established, effective, and equivalent first-line treatmenβ¦
**Definition & Management Overview:** Refractory Status Epilepticus (RSE) is defined as seizure activity that continues despite the administration of an initial benzodiazepine and at least one second-line anti-seizure medication (ASM). In the case described, the patient has failed lorazepam and levetiracetam, necessitaβ¦
### Prevention and Management of Cerebral Vasospasm after Aneurysmal SAH **1. Definitions and Clinical Context** Cerebral vasospasm is a leading cause of delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (SAH). It typically occurs 4 to 14 days after the initial bleed (peak day 7β10). This paβ¦
### Management of a First Unprovoked Seizure in Adults **1. Definitions and Risk of Recurrence** A "first unprovoked seizure" is a single seizure event not triggered by a transient systemic or neurological insult (e.g., hypoglycemia, drug withdrawal). The primary clinical question is the risk of a second seizure (recuβ¦
### Management of Acute Bacterial Meningitis: Stepwise Approach **1. Initial Priorities and the "LP vs. CT" Dilemma** In a patient with the classic triad (fever, neck stiffness, altered mental status), urgent Lumbar Puncture (LP) is diagnostic. However, a Head CT is often performed first to rule out mass effect/increaβ¦
### First-Line Therapy in Young-Onset Parkinson's Disease (YOPD) **1. Clinical Context and Definitions** Young-Onset Parkinson's Disease (YOPD) typically refers to patients diagnosed before age 50. In this case, the 46M software engineer presents with tremor-predominant disease and functional impairment. The goal of tβ¦
### Management of Multiple Sclerosis Relapse: IV vs. Oral Steroids **1. Definitions and Indications** An MS relapse (exacerbation) is defined as new or worsening neurological symptoms lasting >24 hours in the absence of fever or infection (pseudo-relapse). Treatment is indicated for relapses that cause functional impaβ¦
### Management of Chronic Migraine: Preventive Strategies **1. Clinical Context and Indications** Chronic migraine (CM) is defined by the ICHD-3 as β₯15 headache days/month for >3 months, with at least 8 days being migrainous. Preventive therapy is indicated when patients experience significant disability, frequent attβ¦
### Management of Refractory Chronic Migraine: Preventive Strategies **1. Clinical Context and Indications** Chronic migraine (CM) is defined by the ICHD-3 as β₯15 headache days/month for >3 months, with at least 8 days being migrainous. Preventive therapy is indicated when patients experience significant disability, fβ¦
### Management of Refractory Chronic Migraine: Preventive Strategies **1. Clinical Context and Indications** Chronic migraine (CM) is defined by the ICHD-3 as β₯15 headache days/month for >3 months, with at least 8 days being migrainous. Preventive therapy is indicated when patients experience significant disability, fβ¦
### **Step-by-Step Management of Status Epilepticus (SE) and Refractory SE** The management of SE is a time-critical neurological emergency. Following the **Neurocritical Care Society** and **American Epilepsy Society (AES)** guidelines, the management should proceed in distinct phases. #### 1. Current Phase: Urgent β¦
### Management of Delayed Cerebral Ischemia (DCI) Post-SAH **1. Prophylaxis: Nimodipine Protocol** * **Standard Care:** Oral nimodipine is the only medication proven to improve neurological outcomes (by reducing DCI, not necessarily angiographic vasospasm) in patients with aneurysmal SAH. * **Dosing:** 60 mg orally (oβ¦
### Stepwise Approach to Axonal Polyneuropathy **1. Initial Clinical and Electrophysiologic Categorization** * **EMG/NCS:** The first step is to distinguish between axonal (low amplitudes, preserved velocities) and demyelinating (slowed velocities, prolonged latencies, conduction block) patterns. * **Clinical Contextβ¦
### Evaluation of the "Thunderclap" Headache: SNOOP4 and Beyond **1. The SNOOP4 Mnemonic for Red Flags** The SNOOP4 mnemonic is a validated tool to screen for secondary headache etiologies: * **S: Systemic signs/symptoms** (fever, weight loss) or secondary risk factors (HIV, malignancy). * **N: Neurologic signs/symptoβ¦
### Migraine Prophylaxis: Escalating to CGRP-Targeted Therapies **1. Escalation Criteria for CGRP Monoclonal Antibodies (mAbs)** The American Headache Society (AHS) 2024 position statement update suggests that CGRP mAbs (erenumab, fremanezumab, galcanezumab, and eptinezumab) can be considered as first-line or second-lβ¦
### Clinical Differentiation: AD vs. VaD **1. Clinical Presentation** * **Alzheimerβs Disease (AD):** Characterized by insidious onset and gradual, relentless progression. Episodic memory impairment is typically the earliest and most prominent feature. * **Vascular Dementia (VaD):** Often presents with an abrupt onsetβ¦
Spontaneous Pneumothorax Management (BTS/ERS Guidelines): TYPES: - Primary (PSP): No underlying lung disease (your patient - tall young male, first episode) - Secondary (SSP): Underlying lung disease (COPD, asthma, ILD, Marfan) - more serious FIRST: Is it Large or Small? - Large: β₯2 cm rim on CXR at apex (or β₯3 cm byβ¦
Massive Hemoptysis - Definition and Management: DEFINITION: Varies by source, but practically: - >200-600 mL/24 hours OR - Any hemoptysis causing hemodynamic instability or respiratory compromise Your patient: >200 mL + SpO2 dropping = MASSIVE HEMOPTYSIS IMMEDIATE MANAGEMENT (ABCs first): 1. POSITIONING: Lateral decuβ¦
WHO Classification of Pulmonary Hypertension (5 Groups): Group 1 - PAH (Idiopathic/Heritable/Drug-induced/Associated with connective tissue disease, HIV, portal hypertension, congenital heart disease) Group 2 - Left heart disease (most common cause of PH) Group 3 - Lung disease or hypoxia (COPD, ILD, OSA) Group 4 - Chβ¦
NIV (BiPAP) Indications in COPD Exacerbation: CRITERIA FOR NIV INITIATION (any of the following after 1 hour of medical therapy): 1. pH <7.35 AND pCO2 >45 mmHg (respiratory acidosis) 2. Moderate-severe dyspnea with use of accessory muscles 3. RR >25/min 4. PaO2/FiO2 <200 For your patient: pH 7.29, pCO2 68 = MEETS CRIβ¦
CURB-65 vs PSI for Community-Acquired Pneumonia: CURB-65 (simpler, preferred in ED): C - Confusion (new onset): 1 point U - Urea >7 mmol/L (BUN >20 mg/dL): 1 point R - Respiratory Rate β₯30/min: 1 point B - BP <90 systolic or <60 diastolic: 1 point 65 - Age β₯65: 1 point Score Interpretation: 0-1: Low risk β Outpatientβ¦
PE Diagnosis Algorithm (ESC 2019 Guidelines): Step 1: Assess Clinical Probability (Wells Score or Geneva Score) Wells Score: - DVT symptoms: +3 - PE most likely diagnosis: +3 - HR >100: +1.5 - Immobilization/surgery in past 4 weeks: +1.5 - Previous DVT/PE: +1.5 - Haemoptysis: +1 - Cancer: +1 Interpretation: Low <2, Mβ¦
Approach to Unilateral Pleural Effusion: Step 1 - Confirm and Quantify: - CXR: Blunting of costophrenic angle (>200 mL needed) - Ultrasound: Superior to CXR, identifies loculations, guides thoracentesis Step 2 - Thoracentesis MANDATORY when: - First presentation of unilateral effusion (your patient) - Bilateral effusβ¦
Stepwise Management of Acute COPD Exacerbation in ED: IMEDIATE (First 30 minutes): 1. Controlled O2 Therapy: - Target SpO2: 88-92% (NOT higher, risk of hypercapnic drive suppression) - Use 24-28% Venturi mask or 1-2 L/min via nasal cannula - ABG urgently to assess pH, pCO2, pO2 2. Short-acting Bronchodilatorβ¦
Thrombolysis in STEMI - Indications and Contraindications: INDICATIONS: - STEMI within 12 hours of symptom onset (best results if <3 hours) - PCI not available within 120 minutes of first medical contact - New LBBB with symptoms For your patient: door-to-balloon >120 min, no contraindications identified = Thrombolysiβ¦
Complete Heart Block (3rd Degree AV Block) Management: Immediate Actions: 1. IV Atropine 0.5 mg (repeat up to 3 mg total) - may help if block is at AV node level (narrow QRS escape), less effective for infra-Hisian block (wide QRS) 2. If atropine fails: Transcutaneous pacing (TCP) - immediate bridge therapy 3. Dopaminβ¦
Cardiac Tamponade - Clinical Presentation and Management: Classic Triad (Beck's Triad): 1. Hypotension 2. Raised JVP (elevated CVP) 3. Muffled/distant heart sounds Additional Features: - Pulsus paradoxus: fall in SBP >10 mmHg on inspiration (hallmark sign) - Tachycardia (compensatory) - Kussmaul's sign: JVP rises on β¦
Modified Duke Criteria for Infective Endocarditis: MAJOR CRITERIA: 1. Positive blood cultures: Typical organisms (S. viridans, S. bovis, HACEK, S. aureus, Enterococcus) in 2 separate cultures; or persistently positive cultures >12 hours apart 2. Echocardiographic evidence: Oscillating intracardiac mass (vegetation), pβ¦
Indications for Coronary Angiography in Stable Angina: Class I (Strongly Recommended): 1. Persistent symptoms despite OMT (as in your patient) 2. High-risk stress test findings: >2mm ST depression, early positive (<5 METs), ST elevation on exercise, exercise-induced hypotension, large perfusion defect on nuclear imagiβ¦
Rate Control in Atrial Fibrillation: For your patient (no structural heart disease, HR 130, mildly symptomatic): 1st Line Rate Control Drugs: - Beta-blockers (Metoprolol, Bisoprolol): Preferred in most patients; good for sympathetically-driven AF (exercise, stress) - Non-dihydropyridine CCBs (Diltiazem, Verapamil): Gβ¦
Hypertensive Emergency vs Urgency: Hypertensive Emergency: - BP usually >180/120 mmHg WITH acute end-organ damage - Examples: hypertensive encephalopathy, ACLE, aortic dissection, eclampsia, MI, acute LVF, malignant HTN with papilledema - Your case: BP 210/120 + papilledema + confusion = HYPERTENSIVE EMERGENCY Manageβ¦
ICD Indications in HFrEF (ACC/AHA Guidelines): Primary Prevention ICD (Class I): - EF β€35% despite β₯3 months of optimal medical therapy (OMT) - NYHA Class II or III symptoms - Expected meaningful survival >1 year - Ischemic or non-ischemic cardiomyopathy CRT-D Indications (Class I): - EF β€35% + LBBB with QRS β₯150 ms β¦
Key ECG Differences Between STEMI and NSTEMI: STEMI: - ST elevation β₯1 mm in β₯2 contiguous limb leads OR β₯2 mm in β₯2 contiguous precordial leads - New LBBB can be STEMI-equivalent - Posterior STEMI: ST depression in V1-V3 + tall R waves (mirror image) - Hyperacute T waves (earliest sign) - Evolves to Q waves and T wavβ¦
The first-line management of acute decompensated heart failure (ADHF) with pulmonary edema includes: 1. Positioning: Sit patient upright (high Fowler's) to reduce preload. 2. Oxygen/NIV: High-flow O2 or BiPAP/CPAP if SpO2 <90% or persistent respiratory distress. 3. IV Furosemide: 40β80 mg IV bolus (loop diuretic) to rβ¦
Per ERS 2017 Bronchiectasis Guidelines β this patient with BSI 9 (severe), chronic Pseudomonas colonization, and 3-4 exacerbations/year is a high-priority case: **1. Long-term Inhaled Antibiotics (first choice for chronic Pseudomonas):** - **Colistimethate sodium (Promixin/Colobreathe):** Approved in EU for bronchiectβ¦
CPAP non-compliance is a common clinical challenge. Here's the evidence-based stepwise approach for severe OSA (AHI 55): **Step 1: Optimize CPAP Before Switching (AASM 2024)** - Telehealth adherence counseling (motivational interviewing) - Auto-titrating CPAP (APAP): Automatically adjusts pressure 4-20 cmH2O, better tβ¦
Per ESC/ERS 2022 PAH Guidelines β this question is excellently framed. **Risk Stratification First (ESCRHS 2022):** This patient's risk profile: - WHO FC II-III (intermediate) - 6MWD 340m (low-intermediate) - mPAP 48, PVR 8 (high) - TAPSE 14mm (low, RV dysfunction) - No vasoreactivity β NOT a candidate for calcium chaβ¦
Per ATS/ERS/WASOG 2023 Sarcoidosis Management Guidelines: **For this patient (Stage II, asymptomatic, FVC 75%, DLCO 62%):** The short answer is: OBSERVE, do not start steroids yet. **Indications to START Systemic Corticosteroids in Pulmonary Sarcoidosis:** 1. Progressive pulmonary involvement (FVC declining >10% per β¦
Per BTS 2023 Pleural Disease Guidelines for PSP: **Size Assessment:** - BTS uses a simplified 2-zone approach: >2cm visible rim on CXR at hilum level = significant/large pneumothorax. - This patient has 20% collapse β moderate PSP. **BTS 2023 Algorithm for PSP:** 1. **Hemodynamically stable + breathless or large (>2cβ¦
This is a classic TB pleural effusion presentation. Here's the systematic approach: **Light's Criteria Confirmation:** This is an exudate because: - Pleural LDH/Serum LDH = 280/190 = 1.47 (>0.6) β - Pleural protein/Serum protein = 4.2/6.5 = 0.65 (>0.5) β **ADA (Adenosine Deaminase) Interpretation:** - ADA >40 U/L in β¦
Per ATS/ERS/JRS/ALAT 2022 IPF Diagnostic Guidelines β this is well answered: **Is surgical lung biopsy (SLB) needed for typical UIP on HRCT?** NO β a typical UIP pattern on HRCT in the correct clinical context is sufficient for diagnosis without biopsy. ATS/ERS 2022 guidelines state that typical UIP pattern (bilateralβ¦
Per GINA 2023, here's the step-up strategy for uncontrolled moderate-severe asthma: **Step 3 to Step 4 Escalation (your patient):** Her profile β FeNO 48 ppb (high, β₯50 indicates eosinophilic T2 airway inflammation), blood eosinophils 450/uL, 2 exacerbations/year, FEV1 68% β strongly suggests T2-high eosinophilic asthβ¦
Excellent question on a commonly encountered clinical dilemma. Here's the ESC 2019 PE guideline-based approach: **PESI vs sPESI β Practical Use:** - sPESI (simplified) is preferred for bedside use: 1 point each for age >80, cancer, cardiopulmonary disease, HR β₯110, SBP <100, SpO2 <90%. Score 0 = low risk; β₯1 = high riβ¦
This is a critical scenario requiring rapid decision-making. Here's how to approach NIV vs invasive ventilation in acute COPD exacerbation: **Indications for NIV (BiPAP) β GOLD 2023 / BTS guidelines:** - Moderate-severe hypercapnic respiratory failure: pH 7.25β7.35, PaCO2 >45 mmHg - Respiratory rate >25/min despite inβ¦
This presentation is HYPERTENSIVE URGENCY (not emergency), because there is no evidence of acute target-organ damage (no papilledema, no AKI, no troponin rise, no focal neuro deficits, no aortic dissection features). Key distinction: - Hypertensive EMERGENCY = severely elevated BP + acute end-organ damage (hypertensivβ¦
For hemodynamically stable new-onset AF (<48 hours duration), either rate control or rhythm control is acceptable. Key decision points: IMMEDIATE ELECTRICAL CARDIOVERSION is indicated when: - Hemodynamic instability (hypotension, acute pulmonary edema, severe chest pain) - Pre-excitation (WPW + AF) β IV amiodarone/digβ¦
The 2022 AHA/ACC Heart Failure Guidelines recommend initiating all four pillars of GDMT simultaneously or in rapid succession rather than sequential up-titration. Practical sequencing for a stable outpatient like this: 1. Continue beta-blocker (metoprolol succinate already started β continue and uptitrate to target doβ¦
Per ACC/AHA 2013 STEMI guidelines, primary PCI is the preferred reperfusion strategy if door-to-balloon (D2B) time is β€90 min (or β€120 min from first medical contact). Fibrinolysis is preferred when: (1) PCI is unavailable at the presenting facility, AND (2) expected D2B time exceeds 120 minutes from first medical contβ¦